Joseph Bovi, MD

Publications

• In Reply to Peñagarícano

  (Bovi JA, Schultz CJ.) International Journal of Radiation Oncology Biology Physics. 1 February 2021;109(2):641 SCOPUS ID: 2-s2.0-85098481483 02/01/2021

• Multidisciplinary patient-centered management of brain metastases and future directions.

  (Palmer JD, Trifiletti DM, Gondi V, Chan M, Minniti G, Rusthoven CG, Schild SE, Mishra MV, Bovi J, Williams N, Lustberg M, Brown PD, Rao G, Roberge D.) Neurooncol Adv. 2020 Jan-Dec;2(1):vdaa034 PMID: 32793882 PMCID: PMC7415255 08/15/2020

• Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes.

  (Bovi JA, Prah MA, Retzlaff AA, Schmainda KM, Connelly JM, Rand SD, Marszalkowski CS, Mueller WM, Siker ML, Schultz CJ.) Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):979-986 PMID: 32599030 SCOPUS ID: 2-s2.0-85089292279 07/01/2020

• Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow.

  (Tseng CL, Stewart J, Whitfield G, Verhoeff JJC, Bovi J, Soliman H, Chung C, Myrehaug S, Campbell M, Atenafu EG, Heyn C, Das S, Perry J, Ruschin M, Sahgal A.) J Neurooncol. 2020 Sep;149(2):305-314 PMID: 32860571 PMCID: PMC7541359 SCOPUS ID: 2-s2.0-85089972422 08/30/2020

• ACR-ASTRO Practice Parameter for Communication: Radiation Oncology.

  (Schechter NR, Brown DW, Bovi JA, Dominello MM, Liu AK, Mattes MD, Michalski JM, Shih HA, Strom E, Wilkinson JB, Rosenthal SA, Hartford A.) Am J Clin Oncol. 2020 08;43(8):553-558 PMID: 32520791 SCOPUS ID: 2-s2.0-85089126288 06/11/2020

• Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424.

  (Fisher BJ, Pugh SL, Macdonald DR, Chakravatri A, Lesser GJ, Fox S, Rogers CL, Werner-Wasik M, Doyle T, Bahary JP, Fiveash JB, Bovi JA, Howard SP, Michael Yu HH, D'Souza D, Laack NN, Barani IJ, Kwok Y, Wahl DR, Strasser JF, Won M, Mehta MP.) Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):720-725 PMID: 32251755 PMCID: PMC7456814 SCOPUS ID: 2-s2.0-85084750157 04/07/2020

• Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.

  (Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, Bovi JA, Robinson C, Konski A, Khuntia D, Grosshans D, Benzinger TLS, Bruner D, Gilbert MR, Roberge D, Kundapur V, Devisetty K, Shah S, Usuki K, Anderson BM, Stea B, Yoon H, Li J, Laack NN, Kruser TJ, Chmura SJ, Shi W, Deshmukh S, Mehta MP, Kachnic LA, for NRG Oncology.) J Clin Oncol. 2020 04 01;38(10):1019-1029 PMID: 32058845 PMCID: PMC7106984 SCOPUS ID: 2-s2.0-85082562099 02/15/2020

• Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933.

  (Bovi JA, Pugh SL, Sabsevitz D, Robinson CG, Paulson E, Mehta MP, Gondi V, Kundapur V, Shahin MS, Chao ST, Machtay M, DeNittis AS, Laack NN, Greenspoon JN, Moore KN, Huang J, Dominello MM, Kachnic LA.) Adv Radiat Oncol. 2019 Oct-Dec;4(4):579-586 PMID: 31673651 PMCID: PMC6817553 11/02/2019

• Unease With Uncertainty.

  (Bovi J.) Int J Radiat Oncol Biol Phys. 2019 10 01;105(2):244-245 PMID: 31492381 SCOPUS ID: 2-s2.0-85071371866 09/08/2019

• NRG brain tumor specialists consensus guidelines for glioblastoma contouring.

  (Kruser TJ, Bosch WR, Badiyan SN, Bovi JA, Ghia AJ, Kim MM, Solanki AA, Sachdev S, Tsien C, Wang TJC, Mehta MP, McMullen KP.) J Neurooncol. 2019 May;143(1):157-166 PMID: 30888558 PMCID: PMC6483830 SCOPUS ID: 2-s2.0-85063194539 03/20/2019

• Unease With Uncertainty

  (Bovi J.) International Journal of Radiation Oncology Biology Physics. 1 October 2019;105(2):244-245 SCOPUS ID: 2-s2.0-85071371866 10/01/2019

• Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933

  (Bovi JA, Pugh SL, Sabsevitz D, Robinson CG, Paulson E, Mehta MP, Gondi V, Kundapur V, Shahin MS, Chao ST, Machtay M, DeNittis AS, Laack NN, Greenspoon JN, Moore KN, Huang J, Dominello MM, Kachnic LA.) Advances in Radiation Oncology. 2019 SCOPUS ID: 2-s2.0-85070868115 01/01/2019